| Meredith Davis, CNM | |
|
15 Old Rollinsford Rd Ste 102, Dover, NH 03820-2869 | |
| (603) 749-4963 | |
| Not Available |
| Full Name | Meredith Davis |
|---|---|
| Gender | Female |
| Speciality | Certified Nurse Midwife (cnm) |
| Experience | 9 Years |
| Location | 15 Old Rollinsford Rd Ste 102, Dover, New Hampshire |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023479672 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367A00000X | Advanced Practice Midwife | CNM192011 (Maine) | Secondary |
| 367A00000X | Advanced Practice Midwife | 091981-23 (New Hampshire) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Baystate Medical Center | Springfield, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Wentworth Douglass Physician Corporation | 5496749848 | 372 |
News Archive
In this post in the Huffington Post Blog, Dagfinn Hoybraten, vice president of the Norwegian Parliament and chair of the GAVI Alliance Board, examines a nationwide vaccination campaign in Haiti, through which "health officials are targeting measles, rubella and polio and [are] also introducing pentavalent vaccine, one shot against five diseases."
A new, smartphone-enabled otoscope provides clear, transmittable images of the ear drum, or tympanic membrane, which someday may allow for ear infection diagnosis without a visit to the doctor's office, according to an abstract presented Monday, Oct. 28, at the American Academy of Pediatrics National Conference and Exhibition in Orlando.
Columbia Laboratories, Inc. has repurchased 3,333,330 shares of its Common Stock, par value $0.01 per share, from investment funds for which Perry Corp. or an affiliate acts as investment advisor and/or general partner at $0.90 per share for an aggregate total purchase price of approximately $3 million. This transaction reduces the total issued and outstanding shares of Common Stock by about 4% from approximately 84.1 million to 80.8 million. This transaction also reduces the Company's previously forecast 2010 year-end cash balance to approximately $20 million.
The current global epidemic of obesity-linked diabetes and its associated consequences -cardiovascular, neurological and renal diseases - is a growing public health problem for which therapeutic options are limited.
Amgen, Millennium: The Takeda Oncology Company, and Takeda Pharmaceutical Company Limited today announced top-line results from the MONET1 pivotal Phase 3 trial evaluating motesanib administered in combination with paclitaxel and carboplatin in 1,090 patients with advanced non-squamous non-small cell lung cancer.
› Verified 2 days ago
| Entity Name | Wentworth Douglass Physician Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447352430 PECOS PAC ID: 5496749848 Enrollment ID: O20040409000433 |
News Archive
In this post in the Huffington Post Blog, Dagfinn Hoybraten, vice president of the Norwegian Parliament and chair of the GAVI Alliance Board, examines a nationwide vaccination campaign in Haiti, through which "health officials are targeting measles, rubella and polio and [are] also introducing pentavalent vaccine, one shot against five diseases."
A new, smartphone-enabled otoscope provides clear, transmittable images of the ear drum, or tympanic membrane, which someday may allow for ear infection diagnosis without a visit to the doctor's office, according to an abstract presented Monday, Oct. 28, at the American Academy of Pediatrics National Conference and Exhibition in Orlando.
Columbia Laboratories, Inc. has repurchased 3,333,330 shares of its Common Stock, par value $0.01 per share, from investment funds for which Perry Corp. or an affiliate acts as investment advisor and/or general partner at $0.90 per share for an aggregate total purchase price of approximately $3 million. This transaction reduces the total issued and outstanding shares of Common Stock by about 4% from approximately 84.1 million to 80.8 million. This transaction also reduces the Company's previously forecast 2010 year-end cash balance to approximately $20 million.
The current global epidemic of obesity-linked diabetes and its associated consequences -cardiovascular, neurological and renal diseases - is a growing public health problem for which therapeutic options are limited.
Amgen, Millennium: The Takeda Oncology Company, and Takeda Pharmaceutical Company Limited today announced top-line results from the MONET1 pivotal Phase 3 trial evaluating motesanib administered in combination with paclitaxel and carboplatin in 1,090 patients with advanced non-squamous non-small cell lung cancer.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Meredith Davis, CNM Po Box 412503, Boston, MA 02241-2503 Ph: (617) 726-3884 | Meredith Davis, CNM 15 Old Rollinsford Rd Ste 102, Dover, NH 03820-2869 Ph: (603) 749-4963 |
News Archive
In this post in the Huffington Post Blog, Dagfinn Hoybraten, vice president of the Norwegian Parliament and chair of the GAVI Alliance Board, examines a nationwide vaccination campaign in Haiti, through which "health officials are targeting measles, rubella and polio and [are] also introducing pentavalent vaccine, one shot against five diseases."
A new, smartphone-enabled otoscope provides clear, transmittable images of the ear drum, or tympanic membrane, which someday may allow for ear infection diagnosis without a visit to the doctor's office, according to an abstract presented Monday, Oct. 28, at the American Academy of Pediatrics National Conference and Exhibition in Orlando.
Columbia Laboratories, Inc. has repurchased 3,333,330 shares of its Common Stock, par value $0.01 per share, from investment funds for which Perry Corp. or an affiliate acts as investment advisor and/or general partner at $0.90 per share for an aggregate total purchase price of approximately $3 million. This transaction reduces the total issued and outstanding shares of Common Stock by about 4% from approximately 84.1 million to 80.8 million. This transaction also reduces the Company's previously forecast 2010 year-end cash balance to approximately $20 million.
The current global epidemic of obesity-linked diabetes and its associated consequences -cardiovascular, neurological and renal diseases - is a growing public health problem for which therapeutic options are limited.
Amgen, Millennium: The Takeda Oncology Company, and Takeda Pharmaceutical Company Limited today announced top-line results from the MONET1 pivotal Phase 3 trial evaluating motesanib administered in combination with paclitaxel and carboplatin in 1,090 patients with advanced non-squamous non-small cell lung cancer.
› Verified 2 days ago
Mrs. Crystal Guay Morin, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 15 Old Rollinsford Rd Ste 102, Dover, NH 03820 Phone: 603-749-4963 | |
Ms. Elizabeth Elana Schwartz, C.N.M. Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 700 Central Ave, Dover, NH 03820 Phone: 603-742-2424 Fax: 603-742-1763 | |
Lisa Noelle Weinstein, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 770 Central Ave, Dover, NH 03820 Phone: 603-742-0101 Fax: 603-743-3171 | |
Ms. Patricia L Martin, C.N.M. Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 700 Central Ave, Dover, NH 03820 Phone: 603-742-2424 Fax: 603-742-1763 | |
Lauren Walker, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 15 Old Rollinsford Rd Ste 102, Dover, NH 03820 Phone: 603-749-4963 | |
Ms. Nina Marie Harris, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 770 Central Ave, Dover, NH 03820 Phone: 603-742-0101 |